Levosimendan for Hemodynamic Support after Cardiac Surgery

2017290 citationsJournal Articlebronze Open Access

Authors

Giovanni Landoni · Vita-Salute San Raffaele University

В. В. Ломиворотов · Vita-Salute San Raffaele University

Gabriele Alvaro · Azienda Ospedaliero Universitario Mater Domini

Rosetta Lobreglio · Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

Antonio Pisano · Vita-Salute San Raffaele University

Fabio Guarracino · Vita-Salute San Raffaele University

Maria Grazia Calabró

Abstract

In patients who required perioperative hemodynamic support after cardiac surgery, low-dose levosimendan in addition to standard care did not result in lower 30-day mortality than placebo. (Funded by the Italian Ministry of Health; CHEETAH ClinicalTrials.gov number, NCT00994825 .).

Topics & Keywords

Heart Failure Treatment and Management Cardiac Structural Anomalies and Repair Cardiac Arrest and Resuscitation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 376, Issue 21, pp. 2021-2031

DOI: 10.1056/nejmoa1616325

Field-Weighted Citation Impact: 29.26